Table 2.
Clinical and radiographic evaluation of 1st generation bioceramics (MTA) vs. 2nd generation bioceramics (MTA-based).
| Months | n | RR | 95% CI | T | T2 | I2 | z | p-value |
|---|---|---|---|---|---|---|---|---|
| Clinical | ||||||||
| 3 | 4 | 1.00 | 0.97–1.03 | 0.00 | 0.00 | 0.0 | – 0.17 | 0.8656 |
| 6 | 6 | 1.00 | 0.97–1.02 | 0.00 | 0.00 | 0.0 | – 0.14 | 0.8918 |
| 12 | 6 | 1.01 | 0.98–1.04 | 0.00 | 0.00 | 26.6 | 0.49 | 0.6276 |
| 24 | 2 | 0.99 | 0.83–1.17 | 0.00 | 0.00 | 58.3 | – 0.13 | 0.8986 |
| Radiographic | ||||||||
| 3 | 4 | 1.00 | 0.97–1.03 | 0.00 | 0.00 | 0.0 | – 0.17 | 0.8656 |
| 6 | 6 | 1.00 | 0.97–1.02 | 0.00 | 0.00 | 0.0 | – 0.14 | 0.8918 |
| 12 | 6 | 1.01 | 0.98–1.04 | 0.00 | 0.00 | 26.6 | 0.49 | 0.6276 |
| 24 | 2 | 0.99 | 0.83–1.17 | 0.00 | 0.00 | 58.3 | – 0.13 | 0.8986 |
n - number of studies; RR - risk ratio; T - tau; z - z value.